BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 18561941)

  • 1. Nucleation and crystal growth in supersaturated solutions of a model drug.
    Lindfors L; Forssén S; Westergren J; Olsson U
    J Colloid Interface Sci; 2008 Sep; 325(2):404-13. PubMed ID: 18561941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo studies of drug nucleation 1: formation of crystalline clusters of bicalutamide in water.
    Persson R; Nordholm S; Perlovich G; Lindfors L
    J Phys Chem B; 2011 Mar; 115(12):3062-72. PubMed ID: 21384837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
    Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
    Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of Polymeric Additives on Nucleation and Crystal Growth of Indomethacin from Supersaturated Solutions.
    Cheng H; Mao L; Zhang S; Lv H
    AAPS PharmSciTech; 2019 May; 20(5):193. PubMed ID: 31115746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanosized bicalutamide and its molecular structure in solvents.
    Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
    Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Polymer Chain Length on the Physical Stability of Amorphous Drug-Polymer Blends at Ambient Pressure.
    Pacułt J; Rams-Baron M; Chrząszcz B; Jachowicz R; Paluch M
    Mol Pharm; 2018 Jul; 15(7):2807-2815. PubMed ID: 29791165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.
    Szafraniec J; Antosik A; Knapik-Kowalczuk J; Kurek M; Syrek K; Chmiel K; Paluch M; Jachowicz R
    Int J Pharm; 2017 Nov; 533(2):470-479. PubMed ID: 28363855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C; Li C; Le Y; Chen JF
    Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions.
    Pacult J; Rams-Baron M; Chmiel K; Jurkiewicz K; Antosik A; Szafraniec J; Kurek M; Jachowicz R; Paluch M
    Eur J Pharm Sci; 2019 Aug; 136():104947. PubMed ID: 31170526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational polymorphism in bicalutamide.
    Vega DR; Polla G; Martinez A; Mendioroz E; Reinoso M
    Int J Pharm; 2007 Jan; 328(2):112-8. PubMed ID: 16978811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleation of crystals from solution: classical and two-step models.
    Erdemir D; Lee AY; Myerson AS
    Acc Chem Res; 2009 May; 42(5):621-9. PubMed ID: 19402623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
    Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
    Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Influence of Polymers on Supersaturated Flufenamic Acid Cocrystal Solutions.
    Guo M; Wang K; Hamill N; Lorimer K; Li M
    Mol Pharm; 2016 Sep; 13(9):3292-307. PubMed ID: 27494289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
    Prasad D; Chauhan H; Atef E
    Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets.
    Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420
    [No Abstract]   [Full Text] [Related]  

  • 18. Adsorption of Polyvinylpyrrolidone and its Impact on Maintenance of Aqueous Supersaturation of Indomethacin via Crystal Growth Inhibition.
    Patel DD; Anderson BD
    J Pharm Sci; 2015 Sep; 104(9):2923-33. PubMed ID: 26037309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic study on hemipenta hydrate risedronate monosodium in batch crystallization by cooling mode.
    Nguyen TN; Kim KJ
    Int J Pharm; 2008 Nov; 364(1):1-8. PubMed ID: 18582549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.